Do features of central sensitisation exist in Greater Trochanter Pain Syndrome (GTPS)? a case control study

2017 ◽  
Vol 28 ◽  
pp. e13
Author(s):  
H.P. French ◽  
M. McCallan ◽  
C. Jong
2021 ◽  
Vol 9 (2) ◽  
pp. 100314
Author(s):  
So Yun Park ◽  
Eun Sil Lee ◽  
Sa Ra Lee ◽  
Sung Hoon Kim ◽  
Hee Dong Chae

2015 ◽  
Vol 95 (2) ◽  
pp. 227-232 ◽  
Author(s):  
C.Y. Huang ◽  
S.D. Chung ◽  
L.T. Kao ◽  
H.C. Lin ◽  
L.H. Wang

Introduction: Statin may induce epithelial dysfunction of the bladder urothelium. Epithelial dysfunction was proposed as one of the major potential etiologies for bladder pain syndrome/interstitial cystitis (BPS/IC). In this study, we examined the association between statin use and BPS/IC using a population-based study. Subjects and Methods: This case-control study used the Taiwan Longitudinal Health Insurance Database. In total, 815 female subjects with BPS/IC and 4075 randomly selected female controls were included. We used a conditional logistic regression to compute the odds ratio (OR) for having previously used statins between cases and controls. Results: A conditional logistic regression analysis showed that the OR of prior statin users for cases was 1.52 (95% confidence interval (CI): 1.19-1.94) compared to controls after adjusting for diabetes, hypertension, coronary heart disease, obesity, chronic pelvic pain, irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, depression, panic disorder, migraines, sicca syndrome, allergies, endometriosis, and asthma. Furthermore, adjusted ORs of regular and irregular statin use for cases were 1.58 (95% CI: 1.20-2.08) and 1.53 (95% CI: 1.02-2.31), respectively, compared to controls. Conclusion: We concluded that there was an association between statin use and BPS/IC.


2019 ◽  
Vol 49 (5) ◽  
pp. 773-778 ◽  
Author(s):  
Robin Canetti ◽  
Benoit de Saint Vincent ◽  
Thais D. Vieira ◽  
Vincent Fière ◽  
Mathieu Thaunat

2009 ◽  
Vol 17 (5-6) ◽  
pp. 262-268 ◽  
Author(s):  
Ineke van den Berg ◽  
Ylian S. Liem ◽  
Feikje Wesseldijk ◽  
Freek J. Zijlstra ◽  
M.G. Myriam Hunink

CNS Spectrums ◽  
2019 ◽  
Vol 24 (6) ◽  
pp. 605-608
Author(s):  
Juan Manuel Duarte ◽  
Catherine Crow ◽  
Ariel Antik ◽  
Francisco Appiani ◽  
Alejandro Caride

BackgroundFibromyalgia (FM) is a chronic pain syndrome with a controversial etiopathogenesis. Patients with FM usually complain of cognitive symptoms, which are described as “fibrofog.” These cognitive complaints might be caused partially by dissociative disorders (DD). The aim of this research is to determine the association between FM and DD.MethodsThe authors conducted a case-control study for this purpose, integrated by 3 groups: control (C), patients with rheumatic disorders (R), and patients with FM (FM), who were compared through the Dissociative Experiences Scale (DES).The findings are as follows: 42% were taking medications in the FM group, and their differences in scores with those who were not under medications were then considered. In terms of the results, the FM group showed higher scores than both C and R groups (p < 0.05). Patients with FM who were taking antidepressants had lower scores than those who were not (Z-score –8.03; p < 0.05); and finally, 5.71% had a score over 30 (χ2 = 3.73, p = 0.15).ConclusionPatients with FM had higher scores, which might be related to the association of dissociative experiences, lifetime trauma, and victimization. Antidepressants might have some role on dissociative symptoms as well.


Sign in / Sign up

Export Citation Format

Share Document